Home / Tezepelumab / Canada
CA ATC R03DX11 · updated 2 Nov 2026
Tezepelumab shortage in Canada
Is there a Tezepelumab shortage in Canada?
Yes. As of 2 Nov 2026, 1 Tezepelumab product is reported short in Canada. The company estimate for the return is 30 Nov 2026. Main reason: not stated.
Not reported short in any other country we track. All countries.
Affected products in Canada
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | TEZSPIRE (Single use pre-filled syringe) discontinuation | ASTRAZENECA CANADA INC | not given | 30 Nov 2026 | Not stated |
Source
Health Canada, Health Product Shortages Canada. Official list. Mandatory company reports since 2017: actual and anticipated shortages, plus products about to be discontinued.